1. Home
  2. HGBL vs ALGS Comparison

HGBL vs ALGS Comparison

Compare HGBL & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

SELL

Current Price

$1.25

Market Cap

41.6M

ML Signal

SELL

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

SELL

Current Price

$5.39

Market Cap

34.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HGBL
ALGS
Founded
1937
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.6M
34.6M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
HGBL
ALGS
Price
$1.25
$5.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$2.63
★ $52.38
AVG Volume (30 Days)
★ 71.2K
38.7K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 88.30
EPS
★ N/A
N/A
Revenue
★ $20,129,000.00
$2,186,000.00
Revenue This Year
$4.28
$1,562.10
Revenue Next Year
$6.26
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.01
$3.98
52 Week High
$1.58
$13.69

Technical Indicators

Market Signals
Indicator
HGBL
ALGS
Relative Strength Index (RSI) 41.19 43.73
Support Level $1.20 $4.97
Resistance Level $1.28 $6.91
Average True Range (ATR) 0.03 0.32
MACD -0.01 0.01
Stochastic Oscillator 14.23 33.33

Price Performance

Historical Comparison
HGBL
ALGS

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It operates in four segments. The Auction and Liquidation segment, which operates as a full-service auction, appraisal, and asset advisory firm, includes the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment. The Refurbishment & Resale segment acquires, refurbishes, and supplies specialized laboratory equipment. Brokerage segment, through NLEX, brokers charged-off receivables in the U.S. and Canada on behalf of financial institutions. The Specialty Lending segment, which provides specialty financing solutions to investors in charged-off and nonperforming asset portfolios.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: